Phenolphthalein revocation as OTC laxative ingredient urged by Schering-Plough.
This article was originally published in The Tan Sheet
Executive Summary
FDA PHENOLPHTHALEIN BAN URGED BY SCHERING-PLOUGH in June 6 comments to the agency. "In light of the new toxicology information from studies conducted by renowned scientists using generally recognized and accepted methodology and the totality of the toxicology profile of phenolphthalein, we believe it is imperative that [FDA] revoke the approval of phenolphthalein for OTC laxatives effective immediately," Schering-Plough states.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning